Atlas Trials

A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma

Clinical trial NCT00422344 · COMPLETED

Trial details

NCT number
NCT00422344
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Cell CarcinomaKidney Cancer
Start date
2006-10-01
Primary completion
2010-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.